Nature Human Behaviour study finds SilverCloud® by Amwell® reduced prevalence of mental disorders over two years at scale
Amwell (NYSE: AMWL) reported results from a large, NIMH-funded randomized trial of its SilverCloud digital behavioral health platform, published in Nature Human Behaviour.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Amwell (NYSE: AMWL) reported results from a large, NIMH-funded randomized trial of its SilverCloud digital behavioral health platform, published in Nature Human Behaviour. The study followed 6,205 at-risk college students over two years across 26 U.S. campuses.
Students offered SilverCloud showed 74.4% participation versus 30.2% with traditional behavioral health pathways and had 4.3% lower prevalence of any measured mental disorder at six weeks, 4.9% at six months, and 3.8% at two years. According to Amwell, this difference could correspond to about $1.18 million in avoided mental health–related costs within the study sample.
Positive
- Large independent trial: 6,205 students across 26 U.S. colleges and universities
- Participation 74.4% with SilverCloud versus 30.2% with traditional behavioral health pathways
- Lower prevalence of any measured mental disorder: 4.3% at six weeks, 4.9% at six months, 3.8% at two years
- Estimated up to approximately $1.18 million in avoided mental health–related costs within the study sample
- Benefits reported across diverse student groups, including minoritized students and those with financial stress
Negative
- None.
Details
News Market Reaction – AMWL
On May 18, the day this news came out, AMWL closed 2.51% above the previous close.
Data tracked by StockTitan Argus for the May 18 session.
Key Figures
- Students in trial
- 6,205 students
- Clinical or high-risk levels for anxiety, depression, and/or eating disorders
- Institutions involved
- 26 colleges and universities
- U.S. higher education sites participating in the randomized trial
- Students screened
- Nearly 40,000 students
- Screened to identify elevated mental health risk
- SilverCloud participation
- 74.4%
- Participation rate for students offered SilverCloud digital behavioral care
- Traditional participation
- 30.2%
- Participation rate with traditional behavioral health solutions
- Prevalence reduction 6 weeks
- 4.3% lower prevalence
- Any mental disorder vs. in-person care at six weeks
- Prevalence reduction 2 years
- 3.8% lower prevalence
- Any mental disorder vs. in-person care at two years
- Avoided costs
- $1.18 million
- Estimated avoided mental health–related costs within study sample over two years
Historical Context
-
Announcement of participation in virtual Needham technology and media conference.
-
Reported Q1 2026 results and hosted an earnings conference call.
-
Scheduled Q1 2026 results release and related earnings call details.
-
Planned appearance at TD Cowen health care conference with a fireside chat.
-
Grant of 61,559 RSUs to a new employee under inducement plan.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
randomized trial technical
digital behavioral health medical
proactive care model medical
screened medical
economic value financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON, May 18, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today highlighted results from an independently led, National Institute of Mental Health-funded randomized trial published in Nature Human Behaviour examining SilverCloud® by Amwell®, the company’s digital behavioral health solution.
Conducted across 26 U.S. colleges and universities, the study included 6,205 students at clinical or high-risk levels for anxiety, depression, and/or eating disorders, making it one of the largest independent studies of its kind.
The study, led by renowned investigators from Washington University, Penn State University and University of California, Los Angeles, used a proactive care model designed to reach students before conditions worsened. Researchers screened nearly 40,000 students and offered support to those identified as being at elevated risk, rather than relying only on traditional pathways that require students to seek care on their own.
Principal Investigator Michelle G. Newman, PhD, Professor of Psychology and Psychiatry, Penn State University shares her insights on the study:
"Our goal was early detection of those at risk or meeting clinical levels for five mental health conditions, and to test whether digital mental health could move care upstream — reaching people earlier, before symptoms worsen, and doing so at population scale.”
Individuals offered SilverCloud were over twice as likely to engage:
74.4% participation with SilverCloud30.2% participation with traditional behavioral health solutions
Compared to screening and referral to in-person care, those who received digital behavioral healthcare had:
4.3% lower prevalence of having any mental disorder at six weeks4.9% lower prevalence at six months3.8% lower prevalence at two years
This positive impact was consistent across student populations, including minoritized students and those experiencing financial stress. The findings also point to the potential economic value of prevention and earlier intervention at scale.
When asked about the impact of the study, co-investigator Daniel Eisenberg, PhD, Health Economist, Professor of Health Policy and Management, UCLA said,
“The findings suggest meaningful potential economic value. Taking into account the
The findings add to the evidence supporting digital mental health programs as part of a broader care strategy for higher education institutions, health plans, and other organizations seeking to expand access to clinically rigorous support. By combining proactive outreach with a structured digital intervention, the study points to a model that may help address both participation and long-term outcomes in populations with significant unmet need.
About Amwell
Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell Platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell Platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For almost two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.
Investors:
Asher Dewhurst
Media:
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.